At acceptance but before publication, we found article A submitted to journal A was highly similar to article B, published 5 months earlier in conference proceedings in journal B by another publisher. The abstracts were nearly identical, but the author lists and affiliations did not overlap. We asked the authors to explain this and they said article A is their own work, but it was inadvertently leaked by an unnamed medical company they work with.
We told the authors of article A that in future they must declare the role of any company in their research and consider if this may be a conflict of interests. They said their article was previously submitted 4 years ago to another publisher of journal C, who rejected it. We confirmed this with the publisher, who added that their reviewers and editor are not the authors of article B.
The authors of article A said they spoke with the first author of article B, who promised to withdraw it. Article B was retracted, with the abstract being removed and a retraction notice posted. However, the stated reason for retraction was errors. The authors of article A said they were surprised by this.
我们所知道的似乎与文章成为真正作者的作者一致，但文章的作者告诉我们该公司不想参与这一问题，并要求他们撤回我们所做的一篇文章。我们尚未联系B款的作者或出版商。我们向文章A的作者联系联系B第B条的作者和杂志和出版商的作者联系;我们建议他们不一定需要分享公司的详细信息，因为他们是原作者的证据，而第B条的作者则不能，可能足以进行调查。文章的作者说他们会考虑这一点。
Question(s) for the COPE Forum
•我们可以以不同的方式处理这个案例吗？
• Should we contact the publisher of article B?
• Should we ask the institution of the authors of article A and/or article B to investigate?
The Forum was updated that there has been a further development: one of the authors of article A submitted a new article to the journal, a shorter version of which was published in the conference proceedings.
Generally, COPE recommends that authorship issues should be resolved at the institutional level. Institutions are best placed to investigate these issues, especially if there was a medical device company or drug company involved who funded the work. The institution should have a record of this involvement and they may be able to provide additional information. Also, the further misconduct of one of the authors of article A may indicate a pattern of unethical behaviour which needs to be addressed by the journal, but also by the institution.
The Forum was told that the journal plans to contact the author regarding the latest submission, and ask for an explanation. The journal also plans to contact the authors of the conference proceedings to see if they have any insight as to how a different author group submitted the same work to the journal. After evaluating the responses, the journal may then contact the institutions of the authors of article A and possibly also the institutions of the authors of article B. The Forum agreed this was a sensible course of action.
The authors of the latest submission and those of the conference proceeding said they had collaborated, that the conference proceeding was preliminary work, and the authors of the conference proceeding should have been acknowledged in the submission. Because of the similar issue with the previous article by the same authors, the journal still had concerns and declined to further consider the submission. The journal is asking the institutions to investigate.
Follow-up (July 2018)
The journal contacted both institutions and the other publisher. The other publisher thanked the journal for this and said they will take note of their authors' actions; neither institution has responded.